Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: a report of three cases

被引:18
作者
Koller, H
Steurer, W
Mark, W
Margreiter, R
Lhotta, K
Mayer, G
Rosenkranz, AR
机构
[1] Univ Innsbruck Hosp, Dept Nephrol, A-6020 Innsbruck, Austria
[2] Univ Innsbruck Hosp, Dept Transplant Surg, A-6020 Innsbruck, Austria
关键词
transplantation; C4d; acute rejection; humoral rejection; plasmapheresis; immunoadsorption;
D O I
10.1111/j.1432-2277.2004.tb00425.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Acute humoral rejection (AHR) is currently perceived as an immunological reaction against donor antigens mediated by complement-binding antibodies. C4d, a split product of complement activation and bound to endothelial cells of the peritubular capillaries, is used as a diagnostic marker for AHR. We report on three patients with biopsy-proven acute humoral rejection who were treated initially with plasmapheresis (PS). As two of the patients did not recover renal function, and biopsy showed persistent C4d staining after PS, immunoadsorption (IAS) was additionally performed on them. In all patients, renal function recovered, and follow-up biopsies in two patients showed complete disappearance of C4d, 29 days and 58 days after transplantation and only minimal residual C4d deposits in one patient 48 days after transplantation. We conclude that successful treatment of AHR is followed by complete resolution of serological and histological markers of AHR, displayed by the disappearance of C4d.
引用
收藏
页码:177 / 181
页数:5
相关论文
共 20 条
[1]   Plasmapheresis for the treatment of acute vascular rejection in renal transplantation [J].
Aichberger, C ;
Nussbaumer, W ;
Rosmanith, P ;
Riedmann, B ;
Spechtenhauser, B ;
Feichtinger, H ;
Fend, F ;
Pernthaler, H ;
Ofner, D ;
Schonitzer, D ;
Margreiter, R .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :169-170
[2]   LUNG INJURY MEDIATED BY ANTIBODIES TO ENDOTHELIUM .1. IN THE RABBIT A REPEATED INTERACTION OF HETEROLOGOUS ANTI-ANGIOTENSIN-CONVERTING ENZYME ANTIBODIES WITH ALVEOLAR ENDOTHELIUM RESULTS IN RESISTANCE TO IMMUNE INJURY THROUGH ANTIGENIC MODULATION [J].
BARBA, LM ;
CALDWELL, PRB ;
DOWNIE, GH ;
CAMUSSI, G ;
BRENTJENS, JR ;
ANDRES, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :2141-2158
[3]  
Böhmig GA, 2001, J AM SOC NEPHROL, V12, P2482, DOI 10.1681/ASN.V12112482
[4]   INTERACTION OF ANTIBODIES WITH RENAL-CELL SURFACE-ANTIGENS [J].
BRENTJENS, JR ;
ANDRES, G .
KIDNEY INTERNATIONAL, 1989, 35 (04) :954-968
[5]  
Collins AB, 1999, J AM SOC NEPHROL, V10, P2208
[6]   Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics [J].
Crespo, M ;
Pascual, M ;
Tolkoff-Rubin, N ;
Mauiyyedi, S ;
Collins, AB ;
Fitzpatrick, D ;
Farrell, ML ;
Williams, WW ;
Delmonico, FL ;
Cosimi, AB ;
Colvin, RB ;
Saidman, SL .
TRANSPLANTATION, 2001, 71 (05) :652-658
[7]  
Herzenberg AM, 2002, J AM SOC NEPHROL, V13, P234, DOI 10.1681/ASN.V131234
[8]   Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation [J].
Higgins, RM ;
Bevan, DJ ;
Carey, BS ;
Lea, CK ;
Fallon, M ;
Buhler, R ;
Vaughan, RW ;
ODonnell, PJ ;
Snowden, SA ;
Bewick, M ;
Hendry, BM .
LANCET, 1996, 348 (9036) :1208-1211
[9]   Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action [J].
Jordan, SC ;
Quartel, AW ;
Czer, LSC ;
Admon, D ;
Chen, G ;
Fishbein, MC ;
Schwieger, J ;
Steiner, RW ;
Davis, C ;
Tyan, DB .
TRANSPLANTATION, 1998, 66 (06) :800-805
[10]  
Madan AK, 2000, J CLIN APHERESIS, V15, P180, DOI 10.1002/1098-1101(2000)15:3<180::AID-JCA5>3.0.CO